RxDoctor Payments Data

Jonell Poe, PA

Physician Assistant · Augusta, GANPI 1417057977

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Theratechnologies Inc. at 41.4% of the total. Reporting peaked in 2024 at $6,286 and has fallen 67.9% since, to $2,015 in 2025. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,899in general payments, 2019–2025

Across 146 payments — averaging $122.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Theratechnologies Inc.$7K
  • Viiv Healthcare Company$7K
  • Gilead$2K
  • Janssen Scientific Affairs, LLC$1K
  • Johnson & Johnson$431
  • Merck$223
  • plus $76 from 2 others

What the payments were for

  • Consulting fees$6,59037%
  • Speaking & faculty fees$7,15040%
  • Travel & lodging$3712%
  • Food & beverage$3,69921%
  • Education$880%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,899 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$9,168
Medicare patients
36
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala347$1,387,506
TivicayDolutegravir Sodium278$623,671
DescovyEmtricitabine/Tenofov Alafenam246$511,823
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf75$349,872
DovatoDolutegravir Sodium/Lamivudine47$128,046
JulucaDolutegravir/Rilpivirine35$121,508
GenvoyaElviteg/Cob/Emtri/Tenof Alafen30$119,184
OdefseyEmtricitab/Rilpiviri/Tenof Ala30$102,397
TriumeqAbacavir/Dolutegravir/Lamivudi25$97,214
PrezcobixDarunavir/Cobicistat38$87,999
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df25$60,797
StribildElviteg/Cob/Emtri/Tenofo Disop13$54,573
CompleraEmtricita/Rilpivirine/Tenof Df13$46,344
PifeltroDoravirine22$36,017
IsentressRaltegravir Potassium13$30,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy, Genvoya, Stribild$1,634$2,073,086636 claims
Viiv Healthcare CompanyTivicay, Dovato, Juluca, Triumeq$6,931$970,439385 claims
Janssen Products, LPSymtuza$60$349,87275 claims
Johnson & JohnsonPrezcobix, Complera$431$134,34351 claims
MerckPifeltro, Isentress$223$66,12035 claims
Janssen Scientific Affairs, LLCPrezista$1,192$21,79811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →